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Psoriasis is a chronic skin disease in form of papule-shaped lesion and erythematous 
plaques with thick white scales. The pathogenesis of psoriasis involves IL-23/Th-17 
cytokine pathway that contributes the activation of T-lymphocytes and proinflammatory 
cytokines. Treatment of psoriasis using methotrexate has inhibitory effect of the synthesis 
of nucleic acid towards T-lymphocytes and keratinocytes. Ciplukan (Physalis angulata L.) 
has anti-inflammatory potential effect which contains steroid, flavonoid, alkaloid, and 
physalin that may inhibit lymphocyte activation and proinflammatory cytokine production. 
The study is used the method of experimental study with post test only with control group 
design. Thirty five female mices were divided into 7 groups. The parameters of this study 
is anti-psoriatic (PASI and Baker’s score) and lymphocytes count in psoriasis mice model. 
The results of Kruskal-Wallis, PASI and Baker’s score showed that p=0,001 (p<0,05) and 
the result of lymphocytes count using One Way ANOVA showed that p=0,001 (p<0,05). 
The 800 mg/kgBW dose of ciplukan extract showed the largest decrease on PASI score 
and lymphocytes count, and the 1200 mg/kgBW dose one showed the largest decrease on 
the Baker’s score. The present of the 800 mg/kgBW dose of ciplukan extract  gives the 
most optimal effect in reducing PASI score and skin tissue lymphocytes count in psoriasis 
mice model that were not significantly different with the treatment control group, while 
1200 mg/kgBW dose one gives the most optimal effect in reducing Baker’s score that were 
significantly different with the treatment control group. 
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INTRODUCTION 
Psoriasis is a chronic skin condition that is not infectious but can make sufferers 
disabled and reduce their quality of life (WHO, 2016). The skin in psoriasis patients 
appears dry and peeling due to the acceleration of keratinocyte proliferation and can spread 
throughout the body (Keumala et al., 2019). Psoriasis is becoming more common every 
year, and its incidence varies significantly throughout the world. According to data from 
Prof. Dr. Margono Soekarjo Hospital in Purwoketo, patient with psoriasis visited the 
hospital 562 times in 2016 and 705 times from January to August 2017 (Astrid et al., 2018; 
WHO, 2016). 
The pathogenesis of psoriasis involves the interleukin-23/T helper-17 pathway. 
 The cytokine IL-23 induces the differentiation of T-naive cells into Th17 cells in the 
dermis, resulting in IL-17 cytokines, which play an essential role in creating inflammatory 
and chemotactic environments by increasing IL-6, IL-8, and keratinocyte expression of 
ICAM-1 (Polese et al., 2020; Madonna et al., 2015; Lowes et al., 2014;). In addition, there 
are Th1 and T cytotoxic 1 (Tc1) lymphocyte cells produced by IL-12 cytokines that can 
cause lymphocyte infiltration in tissues characterized by keratinocyte hyperproliferation 
acanthosis and hyperkeratosis of skin tissue (Lorthois et al., 2019; Di Cesare et al., 2009; 
Conrad et al. 2007). 
Methotrexate (MTX) as a psoriasis therapy, especially for moderate to severe 
degrees, has serious side effects such as myelosuppression, pulmonary fibrosis, and 
gastrointestinal disorders, even hepatotoxicity (Menting et al., 2016; Pathirana et al., 
2009). Long-term treatment in psoriasis is associated with an increased risk of drug side 
effects, high costs, and low patient adherence (Keumala et al., 2019). These consequences 
and dangers prove that existing treatments are not effective enough to treat psoriasis, so 
this study was conducted to find safer alternative therapies for patient with psoriasis.  
Physalis angulata L., known in Indonesia as "ciplukan," contains the active substance 
physalin, a derivative of steroids, flavonoids, and alkaloids (Nurfiana & Sari, 2018). The 
content of physalin B and F has been shown to have anti-inflammatory and anti-
proliferation effects. The physalin mechanism inhibits lymphocyte proliferation, activation 
of macrophages, and proinflammatory cytokines through inhibition of the Nuclear Factor-
kappaB (NF-kB) cascade (Zhang et al., 2012; Jacobo-Herrera et al., 2006). 
 
MATERIALS AND METHODS 
This research was a type of experimental research with randomized post-test only 
with control group design.  The sample used was a female strain of BALB/c aged 2-3 
months with a healthy weight of 20-25 grams. The mice was obtained from PHPM 
(Pengembangangan Hewan Percobaan Mandiri) in Yogyakarta. Thirty-five mice were 
randomized to be sampled in seven treatment groups.  Group A only applied emollient in 
the form of Noroid cream®, up to 62.5 mg for seven days which had been shaved on the 
back, while Group B applied imiquimod cream 5% up to 62.5 mg (Aldara®; 3M 
Pharmaceuticals, UK) for seven days. Groups C to E received imiquimod cream 5% at a 
dose of up to 62.5 mg/kgBW for 14 days and ciplukan extract at 400, 800, and 1200 
mg/kgBW from day 8 to day 14. Group F was the group that applied imiquimod cream 5% 
to 62.5 mg for 14 days and was given MTX (Ebewe tab 2.5 mg) at 1 mg/kgBW from day 8 
to day 14 orally. Group G was the group that applied imiquimod cream 5% as much as 
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62.5 mg for 14 days and was given a combination of MTX 1 mg/kgBW and ciplukan 
extract 1200 mg/kgBW from day 8 to day 14 orally. 
The manufacture of ciplukan extract using a multilevel maceration method with the 
first solvent was 96% ethanol, the second solvent was n-hexane, and the last solvent was 
ethyl acetate. The extract was made in the Pharmacology Laboratory and the 
Pharmaceutical Laboratory of UNSOED.  The extraction results were also tested for liquid 
chromatography-mass spectrometry (LCMS-MS) test at the Pusat Penelitian Kimia 
Lembaga Ilmu Pengetahuan Indonesia (LIPI) Serpong, South Tangerang, Banten, and 
Thin Layer Chromatography Test at the UNSOED Pharmaceutical Laboratory. 
Furthermore, sampling was conducted at the Pharmacology Laboratory of the 
Faculty of Medicine UNSOED.  The skin tissue was cut on the subcutaneous back of the 
mice taken with a cross section.  Mice skin samples that had been taken were made to 
block paraffin tissue with the coloring of Haematoxylin Eosin (HE) in the Anatomical 
Pathology Laboratory of the Faculty of Medicine, University of Sebelas Maret.  The 
sample reading in the form of PASI score, Baker's score, and calculation of lymphocytes 
count of skin tissue in psoriasis mice model was conducted in the Laboratory of 
Pharmacology of the Faculty of Medicine UNSOED, assisted and guided by dr. Thianti 
Sylviningrum M.Pd.Ked, M.Sc, Sp.KK and Dr. dr. Dody Novrial, M.Si.Med, Sp.PA. 
Univariate analysis was listed in the form of mean and standard deviation. Bivariate 
analysis used the Shapiro-Wilk test as a normality test and the Levene test as a 
homogeneity test. Furthermore, the Kruskal-Wallis non-parametric test was conducted for 
the PASI and Baker's score variables, while the lymphocyte count variable was analyzed 
using the One-Way ANOVA parametric test. 
 
RESULTS AND DISCUSSIONS 
The results of the study included PASI (Psoriasis Area Severity Index) score, 
Baker's scoring system, and the lymphocytes count in mice skin tissue.  
  
   
 
(a) (b) (c) 
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Figure 1. Description of the PASI score of mice. 
Experimental group; group A (a), group B (b), group C (c), group D (d), group E (e), group F (f), group G (g) 
 
The PASI score was used to assess the severity of psoriasis disease while 
simultaneously evaluating the clinical picture of the course of psoriasis disease (Budiastuti, 
2011). The PASI score index was modified for the mouse, namely erythema, 
squama/scales, and skin thickness (van der Fits et al., 2009). Kruskal-Wallis analysis found 
a value of p = 0.001 (p<0.05), which means there is a significant difference in at least two 
groups. 
 
Table I. Results of the bivariate analysis of PASI skor scores 
Groups N 







A 5 0,000 ± 0,000 
<0,05 <0,05 <0,05 
B 5 9,600 ± 2,302 
C 5 0,800 ± 0,447 
D 5 0,200 ± 0,447 
E 5 0,600 ± 0,548 
F 5 0,200 ± 0,447 
G 5 1,600 ± 1,140 
 
Table II. Results of the Baker's Scoring System bivariate analysis 
Groups N 







A 5 0,000 ± 0,000 
<0,05 >0,05 <0,05 
B 5 5,000 ± 1,968 
C 5 2,800 ± 1,440 
D 5 2,600 ± 1,084 
E 5 1,300 ± 0,273 
F 5 1,800 ± 2,079 
G 5 3,100 ± 1,635 
 
Baker's score was used to evaluate histopathological images of psoriasis with scales 
ranging from 0 to 10 (Baker et al., 1992). Kruskal-Wallis test results obtained a 
significance value of 0.001 (p<0.05).  It shows that there is a significant difference in 
average Baker's score between groups. 
 
Table III. Results of bivariate analysis of skin tissue lymphocyte count 
(g) 
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Groups N Mean ± Standard 
Deviation 
p value Description 




B 5 0,958 ± 0,132 
C 5 0,526 ± 0,133 
D 5 0,326 ± 0,068 
E 5 0,437 ± 0,086 
F 5 0,335 ± 0,058 
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Figure 2. Overview of histopathological preparations. 
experimental group (lymphocytes are indicated by red arrows); group A (a), group B (b), group C (c), group 
D (d), group E (e), group F (f), group G (g) 
 
One Way ANOVA test results on the lymphocytes count obtained a significance 
value of 0.000 (p<0.05).  It suggests that there is a significant average difference in the 
lymphocytes count between groups.  Group B, a sick control group with applied 
imiquimod for 14 days, showed a significant difference from the healthy group (Noroid 
cream®).  It means that giving imiquimod (IMQ) could induce psoriasis features both 
clinically and histopathologically. The results are in line with Na Takuathung's study in 
2018 which stated that giving IMQ for seven days can show significant improvements in 
PASI scores and mice histopathological images (acanthosis, epidermal hyperkeratosis, and 
inflammatory cell infiltration) (Na Takuathung et al., 2018). 
The ciplukan extract group dose of 800 mg/kgBW and the MTX group of 1 
mg/kgBW influenced the decrease in PASI score and the lymphocytes count comparable to 
group A.  It means that ciplukan extract doses of 800 mg/kgBW had an effect comparable 
to the 1 mg/kgBW MTX drug on PASI scores and the lymphocytes count in skin tissue. 
 The results support research conducted by Luliana in 2017, which stated that ciplukan 
herbal water extract has anti-inflammatory activity at a dose of 400 mg/kgBW, which also 
mentioned that the increased dose of ciplukan herbal water extract would increase anti-
inflammatory effects (Luliana et al., 2017). These results are also in line with Zong's 
research in 2020, which stated that MTX can improve psoriasis lesions in the form of an 
erythema, thickening of the skin, and squama in male BALB/c mice when applied to 
imiquimod (IMQ) for seven days (Zong et al., 2020). 
Active compounds include alkaloids, flavonoids, steroids/terpenoids, polyphenols, 
tannins, and saponins (Luliana et al., 2017). These active compounds will also affect the 
histopathological features of psoriasis.  The content of physalin B is a secosteroid found in 
ciplukan extract that can inhibit the inflammatory response in macrophages by inhibiting 
NF-kB activation (Yang et al., 2018). The content of physalin F in ciplukan extract can 
inhibit the production of TNF-α, IL-6, IL-12, and NF-kB, which are key inflammatory 
factors in psoriasis (Ji et al., 2012; Jacobo-Herrera et al., 2006). It is contrary to the 
pathogenesis of psoriasis. 
 
CONCLUSION 
The present of the 800 mg/kgBW dose of ciplukan extract  gives the most optimal 
effect in reducing PASI score and skin tissue lymphocytes count in psoriasis mice model 
that were not significantly different with the treatment control group, while 1200 
mg/kgBW dose one gives the most optimal effect in reducing Baker’s score that were 
significantly different with the treatment control group. 
(g) 
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